StreetAlpha.app
Home › Stocks › CVS

CVS HEALTH Corp (CVS)

Healthcare
$85.80
▼ −3.15%
LAST CLOSE · NOV 17

CVS Health runs retail pharmacies, medical clinics and health insurance plans for patients, employers and government programs. It last closed at $85.80 on Nov 17, down 3.15% on the day. CVS reports earnings on Tue, Feb 9, 2027. The average 12-month price target from 5 analysts is $107.60 (+25.4% from the last close), with a high of $112.00 and a low of $104.00. Analyst consensus is Strong Buy, based on the latest ratings from 5 firms (5 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 6 whale options trades in CVS, 67% of them bullish and 33% bearish. In the past 30 days there were 13 dark pool prints totaling $18.5M, the largest $4.6M.

AI Auto Pilots
Is CVS in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$421B
+6.7% vs a year ago
Net income
$11.0B
+2253.3% vs a year ago
EPS (diluted)
$8.61
+2165.8% vs a year ago
Free cash flow
$15.6B
3.7% margin
Valuation
Market cap
$110B
1.28B shares
P/E
10.0
Price over 12 month EPS
Price to sales
0.3
Market cap over revenue
Dividend yield
3.10%
$2.66 a share over 12 months
Balance sheet
Cash & equivalents
$11.7B
At Sep 30
Shareholder equity
$80.5B
Shares outstanding
1.28B
At Oct 28
CEODavid Joyner
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $292B$292BFY2021FY2022: $322B$322BFY2022FY2023: $358B$358BFY2023FY2024: $373B$373BFY2024FY2025: $402B$402BFY2025

From CVS's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Next report
Feb 9
2027 · Time not announced
Consensus EPS forecast
$1.08
$107.78B revenue est.
Year-ago EPS
$1.09
Same quarter last year
Options-implied move
—
Posted about a week before
Analyst consensus
Strong Buy
Based on 5 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
5firms
5 Buy0 Hold0 Sell
Each firm's latest rating on CVS in the past 90 days
Average 12-month target
$107.60
▲ 25.4% upside

Based on 5 analysts who set a price target on CVS in the past 90 days. The average target is $107.60, with a high of $112.00 and a low of $104.00, compared with the last close of $85.80.

$81$92$103$114PAST 108 TRADING DAYS12-MONTH TARGETSHIGH $112AVG $107.60LOW $104May 22LAST CLOSE+12 MO$81$92$103$114PAST 108 DAYSTARGETSHIGH $112AVG $107.60LOW $104May 22LAST CLOSE+12 MO
Highest target$112.00
Average target$107.60
Lowest target$104.00
Latest rating changes
RBC CapitalTarget lowered
Nov 16Buy$113 → $108
Wells FargoTarget lowered
Nov 12Buy$123 → $112
UBSTarget lowered
Nov 6Buy$118 → $107
Leerink PartnersTarget lowered
Nov 5Buy$112 → $104
BarclaysTarget lowered
Nov 5Buy$108 → $107
DateFirmActionRatingPrice target
Nov 16RBC CapitalTarget loweredBuy$113 → $108
Nov 12Wells FargoTarget loweredBuy$123 → $112
Nov 6UBSTarget loweredBuy$118 → $107
Nov 5Leerink PartnersTarget loweredBuy$112 → $104
Nov 5BarclaysTarget loweredBuy$108 → $107
Loading…

Technical Analysis

CVS · as of the Nov 17 close · updated after every close
Turning down

The stock is 4% below its 20 day and 4% below its 50 day average. It is 4% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 44). The nearest support is the Pivot at $85.79, and the nearest resistance the Pivot R1 at $86.90.

Short trendBearish
Long trendNeutral
MomentumNeutral
StretchNormal
VolatilityHigh, 3.6%/day
Key levels
$110.6852 week high+29.0%
$94.96100 day average+10.7%
$89.93Swing high (Oct 7)+4.8%
$89.2950 day average+4.1%
$89.29200 day average+4.1%
$88.9020 day average+3.6%
$86.90Pivot R1+1.3%
$85.80Last close
$85.79Pivot−0.0%
$84.69Pivot S1−1.3%
$84.50Swing low (Sep 24)−1.5%
$69.5152 week low−19.0%
Indicators
RSI (14)43.63Middle of its rangeNeutral
MACD-0.74Above its signal lineBullish
Stochastic70.4Middle of its rangeNeutral
ADX (14)19.9No clear trend
Williams %R-42.1Oversold below −80, overbought above −20Neutral
CCI (20)-70.0Oversold below −100, overbought above 100Neutral
Rate of change−6.1%Change over 10 sessionsBearish
ATR (14)$3.05Typical daily range, 3.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CVS

What happened before

See how CVS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow leans bullish4 bullish and 2 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow CVS usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How CVS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
6
Bullish
4
67%
Bearish
2
33%
Date span
Aug 26 – Nov 11
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
13
Notional
$18.5M
Largest print
$4.6M
Loading…

CVS Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ●925 buying vs 939 selling
  • ▼Held by funds -3.2 pts
  • ▼Funds holding -93
  • ▼Superinvestors: 1 added, 5 cut
  • ▼Put/call 1.05 to 1.34
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1,9902,083−4.5%
In funds' top 101631−48.4%
Held by funds86.7%89.8%−3.2 pts
New / increased137 / 788301 / 762−13.0%
Reduced / sold out737 / 202735 / 110+11.1%
Put/call ratio1.341.05+28.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CVS institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

CVS Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
—
 
Left in program
$11.5B
10.5% of value
Shares outstanding, 12 months
+0.8%
More shares
Last quarter
$0
Sep 2026
Avg price paid, last quarter
—
 
S&P 500 rank by spending
—
 
Spent each quarter, last 3 yearsTop bar $3.0B
Dec 2023: $0Mar 2024: $3.0B, average price $75.57Jun 2024: $0Sep 2024: $0Dec 2024: $0Mar 2025: $0Jun 2025: $0Sep 2025: $0Dec 2025: $0Mar 2026: $0Jun 2026: $0Sep 2026: $0
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Nov 4, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CVS is in one of them and how their past CVS trades turned out.

CVS in the AI portfolios
Loading…

CVS News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CVS in an article yet. Here's the latest on the wider market.

CVS Congress Trades

All congress trades →
Trades, 12 months
24
Buys
12
50%
Sells
12
50%
People
9
Last filed Nov 11
Who traded CVS · since 2014
Latest 5 filings of 245
$1K – $15KTraded Jun 2, 2026Filed Nov 11, 2026
$1K – $15KTraded Oct 13, 2026Filed Nov 5, 2026
$1K – $15KTraded Oct 13, 2026Filed Nov 5, 2026
$15K – $50KTraded Sep 4, 2026Filed Oct 7, 2026
$100K – $250KTraded Jul 31, 2026Filed Sep 22, 2026
PersonTypeAmountTradedFiledDelay
Arjun ModyExecutive branchSell$1K – $15KJun 2, 2026Nov 11, 2026162 d
Ro KhannaD · CABuy$1K – $15KOct 13, 2026Nov 5, 202623 d
Ro KhannaD · CASell$1K – $15KOct 13, 2026Nov 5, 202623 d
Ro KhannaD · CASell$15K – $50KSep 4, 2026Oct 7, 202633 d
Donald J TrumpExecutive branchSell$100K – $250KJul 31, 2026Sep 22, 202653 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About CVS HEALTH

CVS Health is a health care company based in Woonsocket, Rhode Island. It runs retail drugstores and medical clinics, operates a pharmacy benefits manager, and sells health insurance plans, including Medicare Advantage and Medicare prescription drug plans. Its customers include patients who use its stores and clinics, plan members, employer groups and government programs.

Headquarters
Woonsocket, RI
Founded
1963